To include your compound in the COVID-19 Resource Center, submit it here.

MSMB launches bid for AMAG

AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) said it received an unsolicited offer from shareholder MSMB Capital

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE